Georgia's Online Cancer Information Center

Oral Cancer Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Oral Cancer
Cancer Type = Oral Cancer
There are currently 10 active Oral Cancer clinical trials in Georgia.
2.
A Phase I / II Study of Concurrent Cetuximab and Nivolumab in Patients with Recurrent and / or Metastatic Head and Neck Squamous Cell Carcinoma
Cancer Type
Head and Neck Cancer, Oral Cancer, Unknown Primary
NCT ID
NCT03370276
Protocol IDs
MCC-19178
NCI-2017-02373
Treatment Sites (1)
3.
A Phase I Study of VX-970 in Combination with Cisplatin and XRT in Patients with Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma (HNSCC; SDC 10060121)
Cancer Type
Head and Neck Cancer, Oral Cancer
NCT ID
NCT02567422
Protocol IDs
9950
NCI-2015-01643
Treatment Sites (2)
Emory University Hospital - Midtown
Atlanta
Scott Edelman
404-686-4411
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
4.
A Phase II Trial of Pembrolizumab and Cabozantinib in Patients with RM SCCHN Who Have Failed Platinum Based Therapy
Cancer Type
Head and Neck Cancer, Oral Cancer, Skin Cancer (Non-Melanoma), Unknown Primary
NCT ID
NCT03468218
Protocol IDs
Winship4234-17
NCI-2017-02419
IRB00100269
Treatment Sites (1)
Emory University Hospital - Midtown
Atlanta
Scott Edelman
404-686-4411
5.
A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer
Cancer Type
Head and Neck Cancer, Oral Cancer
NCT ID
NCT01141231
Protocol IDs
97115
NCI-2011-02073
CDR0000674208
WF 97115
WFU-97115
MDA-04-01
6.
A Randomized, Phase II Study of Ficlatuzumab with or without Cetuximab in Patients with Cetuximab-Resistant, Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Cancer Type
Head and Neck Cancer, Oral Cancer, Unknown Primary
NCT ID
NCT03422536
Protocol IDs
1710965268
NCI-2017-02209
AVEO
AV-299-17-117i
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
7.
Phase II Randomized Study of Adjuvant Radiotherapy With Versus Without Concurrent Chemotherapy in Patients With Resected High-Risk Malignant Salivary Gland Tumors
Cancer Type
Oral Cancer
NCT ID
NCT01220583
Protocol IDs
RTOG-1008
RTOG-1008
Treatment Sites (2)
Emory University Hospital - Midtown
Atlanta
Scott Edelman
404-686-4411
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
8.
Phase II Randomized Trial of Adjuvant Radiotherapy with or without Cisplatin for P53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Cancer Type
Head and Neck Cancer, Oral Cancer
NCT ID
NCT02734537
Protocol IDs
EA3132
NCI-2015-01911
Treatment Sites (2)
Emory University Hospital - Midtown
Atlanta
Scott Edelman
404-686-4411
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
9.
Randomized Phase II / III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin
Cancer Type
Head and Neck Cancer, Oral Cancer
NCT ID
NCT03258554
Protocol IDs
NRG-HN004
NRG-HN004
NCI-2017-01522
Treatment Sites (3)
Augusta University Medical Center
Augusta
Carol Terry
706-721-4430
Emory University Hospital - Midtown
Atlanta
Scott Edelman
404-686-4411
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.